Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis
Clinical trial NCT06398652 · COMPLETED
Trial details
- NCT number
- NCT06398652
- Sponsor
- Taizhou Mabtech Pharmaceutical Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-27
- Primary completion
- 2025-06-30
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.